Pharming Group (PHARM)

[plumo]

Pharming Updates On Shares In Issue

Leiden, The Netherlands, July 6, 2012. Biotech company Pharming Group NV (“Pharming” or “the Company”) (NYSE Euronext: PHARM) announced today that it issued the final amount of shares due to bondholders.

As announced in Pharming’s press release dated December 23, 2011; under the €8.4 million private bond, which has now been redeemed in shares in full, a top- up payment in shares caused by the drop in share price over the last month has become due. Therefore 35,256,025 shares will be issued to the bondholders. This is the final payment under the terms and conditions of the bond.

As of today, the number of outstanding shares has increased from 688,992,651 to 724,248,676.